Literature DB >> 15580331

[A rare cause of subacute parotitis. The pathogenetic role of crystals from an infarcted Whartin's tumour?].

M Rössle1, W Winter, S Ihrler.   

Abstract

The etiology of a subacute inflammatory swelling in the area of the right parotid gland in a 62-years old man could not be resolved clinically. The histomorphological examination of the surgical specimen showed an intraglandular area of predominantly chronic histiocytic inflammation with foreign body reaction in the intimate neighbourhood of a small, subtotally infarcted Warthin's tumour. Not birefringent spindle-shaped crystals could be demonstrated both within the parotitis or intraluminally in vital parts of the Warthin's tumour. In terms of the possible causes of the severe intraglandular inflammation, all arguments favour a primary infarction of the Warthin's tumour with the release of intraluminal preformed crystals which secondarily induce a massive inflammation with foreign body reaction, corresponding to the clinical presentation of a subacute parotitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15580331     DOI: 10.1007/s00106-004-1193-y

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  12 in total

1.  Xanthogranulomatous sialadenitis following diagnosis of Warthin's tumour: a possible complication of fine needle aspiration (FNA).

Authors:  M R Stephen; I Matalka; C J Stewart; K Mackenzie
Journal:  Cytopathology       Date:  1999-08       Impact factor: 2.073

2.  Necrotizing squamous/mucinous metaplasia in oncocytic salivary gland tumors. A potential diagnostic problem.

Authors:  J B Taxy
Journal:  Am J Clin Pathol       Date:  1992-01       Impact factor: 2.493

Review 3.  [Etiology and differential diagnosis of sialadenitis].

Authors:  G Seifert
Journal:  Laryngorhinootologie       Date:  1995-05       Impact factor: 1.057

Review 4.  [Differential diagnosis of lymphoepithelial lesions of salivary glands. With particular reference to characteristic duct lesions].

Authors:  S Ihrler; C Zietz; A Sendelhofert; F Menauer; S Blasenbreu-Vogt; U Löhrs
Journal:  Pathologe       Date:  2000-11       Impact factor: 1.011

5.  Tumour-simulating squamous cell metaplasia (SCM) in necrotic areas of salivary gland tumours.

Authors:  K Donath; G Seifert
Journal:  Pathol Res Pract       Date:  1997       Impact factor: 3.250

6.  Infarcted ('infected') adenolymphomas. A clinicopathological study of 20 cases.

Authors:  J W Eveson; R A Cawson
Journal:  Clin Otolaryngol Allied Sci       Date:  1989-06

7.  Warthin's tumor (cystadenolymphoma) of salivary glands. A clinicopathologic investigation of 278 cases.

Authors:  J W Eveson; R A Cawson
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1986-03

8.  Histologic subclassification of the cystadenolymphoma of the parotid gland. Analysis of 275 cases.

Authors:  G Seifert; H G Bull; K Donath
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

9.  Corpora amylacea in adenolymphoma (Warthin's tumor).

Authors:  R David; A Buchner
Journal:  Am J Clin Pathol       Date:  1978-02       Impact factor: 2.493

Review 10.  Granulomatous sialadenitis.

Authors:  J G Batsakis
Journal:  Ann Otol Rhinol Laryngol       Date:  1991-02       Impact factor: 1.547

View more
  3 in total

1.  [Patterns of xanthogranulomatous reaction in salivary glands. Histomorphological spectrum and differential diagnosis].

Authors:  A Agaimy; S Ihrler
Journal:  Pathologe       Date:  2014-03       Impact factor: 1.011

2.  [Case report of granulomatous necrotizing sialadenitis. Rarity of first manifestation in submandibular gland].

Authors:  T Schaller; B Märkl; F X Brunner; R Brill; C Oetzel; H Arnholdt; S Ihrler
Journal:  Pathologe       Date:  2014-03       Impact factor: 1.011

3.  Differential diagnosis of parotid gland tumours: which magnetic resonance findings should be taken in account?

Authors:  T Tartaglione; A Botto; M Sciandra; S Gaudino; L Danieli; C Parrilla; G Paludetti; C Colosimo
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-10       Impact factor: 2.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.